Kiora Pharmaceuticals Announces Exclusive License Agreement With Chong Kun Dang For KIO-301 In South Korea For $1M Upfront, Plus Milestones And Royalties

뉴스 본문을 불러오고 있어요.

Kiora Pharmaceuticals Announces Exclusive License Agreement With Chong Kun Dang For KIO-301 In South Korea For $1M Upfront, Plus Milestones And Royalties | 웨이프 WAPE

Kiora Pharmaceuticals Announces Exclusive License Agreement With Chong Kun Dang For KIO-301 In South Korea For $1M Upfront, Plus Milestones And Royalties

기사 요약

관련 종목

댓글 —